Search
Descriptor English: Fulvestrant
Descriptor Spanish: Fulvestrant
Descriptor fulvestrant
Entry term(s) 7-(9-(4,4,5,5,5-pentafluoropentilsulfinil)nonil)estra-1,3,5(10)-trieno-3,17-diol
Faslodex
ICI 182,780
ICI 182780
ICI-182780
ICI182780
ZM 182780
ZM-182780
ZM182780
Scope note: Derivado del estradiol y antagonista de los receptores de estrógenos que se usa para el tratamiento del cáncer de mama con receptores de estrógenos positivos localmente avanzado o metastásico.
Descriptor Portuguese: Fulvestranto
Descriptor French: Fulvestrant
Entry term(s): 7-(9-(4,4,5,5,5-pentafluoropentylsulfinyl)nonyl)estra-1,3,5(10)-triene-3,17-diol
Faslodex
ICI 182,780
ICI 182780
ICI-182780
ICI182780
ZM 182780
ZM-182780
ZM182780
Tree number(s): D04.210.500.365.415.248.660
D06.472.334.851.437.500.500
RDF Unique Identifier: https://id.nlm.nih.gov/mesh/D000077267
Scope note: An estradiol derivative and estrogen receptor antagonist that is used for the treatment of estrogen receptor-positive, locally advanced or metastatic breast cancer.
Allowable Qualifiers: AA analogs & derivatives
AD administration & dosage
AE adverse effects
AG agonists
AI antagonists & inhibitors
AN analysis
BL blood
CF cerebrospinal fluid
CH chemistry
CL classification
CS chemical synthesis
EC economics
HI history
IM immunology
IP isolation & purification
ME metabolism
PD pharmacology
PK pharmacokinetics
PO poisoning
RE radiation effects
SD supply & distribution
ST standards
TO toxicity
TU therapeutic use
UR urine
Pharm Action: Antineoplastic Agents, Hormonal
Estrogen Receptor Antagonists
Registry Number: 22X328QOC4
Public MeSH Note: 2019; FULVESTRANT was indexed under ESTRADIOL/analogs & derivatives 1991-2019
History Note: 2019 (1991)
DeCS ID: 57570
Unique ID: D000077267
Documents indexed in the Virtual Health Library (VHL): Click here to access the VHL documents
Date Established: 2019/01/01
Date of Entry: 2018/07/09
Revision Date: 2018/06/19
Fulvestrant - Preferred
Concept UI M0397101
Scope note An estradiol derivative and estrogen receptor antagonist that is used for the treatment of estrogen receptor-positive, locally advanced or metastatic breast cancer.
Preferred term Fulvestrant
Entry term(s) 7-(9-(4,4,5,5,5-pentafluoropentylsulfinyl)nonyl)estra-1,3,5(10)-triene-3,17-diol
Faslodex - Narrower
Concept UI M0393766
Preferred term Faslodex
ICI 182780 - Narrower
Concept UI M0191035
Preferred term ICI 182780
Entry term(s) ICI 182,780
ICI-182780
ICI182780
ZM 182780 - Narrower
Concept UI M0434029
Preferred term ZM 182780
Entry term(s) ZM-182780
ZM182780



We want your feedback on the new DeCS / MeSH website

We invite you to complete a survey that will take no more than 3 minutes.

Go to survey